In vivo inhibition of renal heme oxygenase with an imidazole-dioxolane inhibitor

Pharmacological Research

Volumn 61, Issue 6, 2010, Pages 525-530

  Csongradi, Eva ^a   Vera, Trinity ^a   Rimoldi, John M ^b   Gadepalli, Rama S V ^b   Stec, David E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Carbon monoxide; Cobalt protoporyphrin; Heme oxygenase 1; Kidney; Mouse

Indexed keywords

2 [2 (4 CHLOROPHENYL)ETHYL] 2 [(1H IMIDAZOL 1 YL)METHYL] 4 METHYL 1,3 DIOXOLANE; HEME OXYGENASE; HEME OXYGENASE INHIBITOR; PROTOPORPHYRIN COBALT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG DETERMINATION; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTAL MOUSE; IN VIVO STUDY; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; DIOXOLANES; HEME OXYGENASE (DECYCLIZING); IMIDAZOLES; KIDNEY; MALE; MICE; MICE, INBRED C57BL;

EID: 77952885752     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2010.02.006     Document Type: Article

References (34)

1. Abraham N.G., Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008, 60:79-127.
2. Yang L., Quan S., Nasjletti A., Laniado-Schwartzman M., Abraham N.G. Heme oxygenase-1 gene expression modulates angiotensin II-induced increase in blood pressure. Hypertension 2004, 43:1221-1226.
3. Botros F.T., Schwartzman M.L., Stier C.T., Goodman A.I., Abraham N.G. Increase in heme oxygenase-1 levels ameliorates renovascular hypertension. Kidney Int 2005, 68:2745-2755.
4. Sabaawy H.E., Zhang F., Nguyen X., ElHosseiny A., Nasjletti A., Schwartzman M., et al. Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension 2001, 38:210-215.
5. Vera T., Kelsen S., Yanes L.L., Reckelhoff J.F., Stec D.E. HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice. Am J Physiol Regul Integr Comp Physiol 2007, 292:R1472-R1478.
6. Katori M., Buelow R., Ke B., Ma J., Coito A.J., Iyer S., et al. Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptotic pathway. Transplantation 2002, 73:287-292.
7. Kato H., Amersi F., Buelow R., Melinek J., Coito A.J., Ke B., et al. Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant 2001, 1:121-128.
8. Yet S.F., Tian R., Layne M.D., Wang Z.Y., Maemura K., Solovyeva M., et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 2001, 89:168-173.
9. Shimizu H., Takahashi T., Suzuki T., Yamasaki A., Fujiwara T., Odaka Y., et al. Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med 2000, 28:809-817.
10. Kappas A., Drummond G.S., Simionatto C.S., Anderson K.E. Control of heme oxygenase and plasma levels of bilirubin by a synthetic heme analogue, tin-protoporphyrin. Hepatology 1984, 4:336-341.
11. Anderson K.E., Simionatto C.S., Drummond G.S., Kappas A. Tissue distribution and disposition of tin-protoporphyrin, a potent competitive inhibitor of heme oxygenase. J Pharmacol Exp Ther 1984, 228:327-333.
12. Vreman H.J., Ekstrand B.C., Stevenson D.K. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity. Pediatr Res 1993, 33:195-200.
13. Appleton S.D., Chretien M.L., McLaughlin B.E., Vreman H.J., Stevenson D.K., Brien J.F., et al. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations. Drug Metab Dispos 1999, 27:1214-1219.
14. Ignarro L.J., Ballot B., Wood K.S. Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. J Biol Chem 1984, 259:6201-6207.
15. Meffert M.K., Haley J.E., Schuman E.M., Schulman H., Madison D.V. Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins. Neuron 1994, 13:1225-1233.
16. Cable E.E., Gildemeister O.S., Pepe J.A., Lambrecht R.W., Bonkovsky H.L. Mechanism of induction of heme oxygenase by metalloporphyrins in primary chick embryo liver cells: evidence against a stress-mediated response. Mol Cell Biochem 1997, 169:13-20.
17. Shan Y., Pepe J., Lu T.H., Elbirt K.K., Lambrecht R.W., Bonkovsky H.L. Induction of the heme oxygenase-1 gene by metalloporphyrins. Arch Biochem Biophys 2000, 380:219-227.
18. Vlahakis J.Z., Kinobe R.T., Bowers R.J., Brien J.F., Nakatsu K., Szarek W.A. Imidazole-dioxolane compounds as isozyme-selective heme oxygenase inhibitors. J Med Chem 2006, 49:4437-4441.
19. Kinobe R.T., Vlahakis J.Z., Vreman H.J., Stevenson D.K., Brien J.F., Szarek W.A., et al. Selectivity of imidazole-dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms. Br J Pharmacol 2006, 147:307-315.
20. Kinobe R.T., Ji Y., Vlahakis J.Z., Motterlini R., Brien J.F., Szarek W.A., et al. Effectiveness of novel imidazole-dioxolane heme oxygenase inhibitors in renal proximal tubule epithelial cells. J Pharmacol Exp Ther 2007, 323:763-770.
21. Vera T., Kelsen S., Stec D.E. Kidney-specific induction of heme oxygenase-1 prevents angiotensin II hypertension. Hypertension 2008, 52:660-665.
22. Stec D.E., Vera T., Storm M.V., McLemore G.R., Ryan M.J. Blood pressure and renal blow flow responses in heme oxygenase-2 knockout mice. Am J Physiol Regul Integr Comp Physiol 2009, 297:R1822-R1828.
23. Lu S., Roman R.J., Mattson D.L., Cowley A.W. Renal medullary interstitial infusion of diltiazem alters sodium and water excretion in rats. Am J Physiol 1992, 263:R1064-R1070.
24. Heyman S.N., Fuchs S., Brezis M. The role of medullary ischemia in acute renal failure. New Horiz 1995, 3:597-607.
25. Yamamoto K., Wilson D.R., Baumal R. Outer medullary circulatory defect in ischemic acute renal failure. Am J Pathol 1984, 116:253-261.
26. Vickers A.E., Rose K., Fisher R., Saulnier M., Sahota P., Bentley P. Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology. Toxicol Pathol 2004, 32:577-590.
27. Taguchi T., Nazneen A., Abid M.R., Razzaque M.S. Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 2005, 148:107-121.
28. Goodman A.I., Olszanecki R., Yang L.M., Quan S., Li M., Omura S., et al. Heme oxygenase-1 protects against radiocontrast-induced acute kidney injury by regulating anti-apoptotic proteins. Kidney Int 2007, 72:945-953.
29. Agarwal A., Balla J., Alam J., Croatt A.J., Nath K.A. Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. Kidney Int 1995, 48:1298-1307.
30. Shiraishi F., Curtis L.M., Truong L., Poss K., Visner G.A., Madsen K., et al. Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol 2000, 278:F726-F736.
31. Toda N., Takahashi T., Mizobuchi S., Fujii H., Nakahira K., Takahashi S., et al. Tin chloride pretreatment prevents renal injury in rats with ischemic acute renal failure. Crit Care Med 2002, 30:1512-1522.
32. Rodriguez F., Kemp R., Balazy M., Nasjletti A. Effects of exogenous heme on renal function: role of heme oxygenase and cyclooxygenase. Hypertension 2003, 42:680-684.
33. Zou A.P., Billington H., Su N., Cowley A.W. Expression and actions of heme oxygenase in the renal medulla of rats. Hypertension 2000, 35:342-347.
34. Li N., Yi F., Dos Santos E.A., Donley D.K., Li P.L. Role of renal medullary heme oxygenase in the regulation of pressure natriuresis and arterial blood pressure. Hypertension 2007, 49:148-154.